Compare ATOM & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOM | WGRX |
|---|---|---|
| Founded | 2001 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 60.2M |
| IPO Year | 2016 | 2025 |
| Metric | ATOM | WGRX |
|---|---|---|
| Price | $2.29 | $0.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 443.2K | ★ 1.3M |
| Earning Date | 10-28-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $38,000.00 | ★ $34,077,635.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $300.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 495.93 |
| 52 Week Low | $1.89 | $0.34 |
| 52 Week High | $17.55 | $7.04 |
| Indicator | ATOM | WGRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 46.86 |
| Support Level | $1.89 | $0.55 |
| Resistance Level | $2.48 | $0.66 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 63.07 | 47.44 |
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.